Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Medical Aesthetics and Cosmetology ; (6): 227-230, 2023.
Artigo em Chinês | WPRIM | ID: wpr-995932

RESUMO

Objective:To investigate the clinical efficacy of botulinum toxin A in the treatment of hand hyperhidrosis.Methods:One hundred patients with hand hyperhidrosis were treated with botulinum toxin A (BTXA, Lanzhou Biotechnology Development Co., Ltd., Botulinum Toxin Type A for Injection Hengli) injection, a total of 200 U. Each hand was injected with 100 U respectively. The curative effect was evaluated by self-made questionnaire. The scores of the two were added. The subjective and objective evaluation were carried out before and after injection, and the patients were rechecked 2 weeks, and 1, 4 and 6 months after injection. Efficacy, patient satisfaction and adverse reactions were evaluated.Results:Compared with before treatment, the effective rate increased 2 weeks after injection, 1 month after injection, 4 months after injection and 6 months after injection, and the difference was statistically significant (Chi-square value was 31.54, 36.33, 28.34, 25.23, respectively, P<0.05). After 6 months of follow-up, the effect gradually decreased, and the curative effect could be maintained for about 10 months. After recurrence, the symptoms of hand sweating were still reduced. Satisfaction 96%; Adverse reactions were mild, subcutaneous blood stasis, 27% hand muscles were slightly weak, and returned to normal after 2-3 weeks. Conclusions:Botulinum toxin A injection has certain curative effect, high safety and less adverse reactions. It is an ideal method for the treatment of hand hyperhidrosis.

2.
Chinese Journal of Medical Genetics ; (6): 409-412, 2022.
Artigo em Chinês | WPRIM | ID: wpr-928430

RESUMO

OBJECTIVE@#To explore the clinical features and genetic etiology for a neonate with Smith-Magenis syndrome (SMS).@*METHODS@#Copy number variation sequencing (CNV-seq) was applied to the neonate and his parents, and the genotype-phenotype correlation was analyzed.@*RESULTS@#On the second day after birth, the neonate had presented with pathological jaundice and immunodeficiency. Cranial MRI revealed ventricular enlargement and enlargement of cisterna magna. At 3 months, the infant has presented with square face, prominent forehead, deep-set eyes, hypertelorism, palpebral fissure upward and button noses. Genetic testing showed that he had carried a 2.9 Mb deletion in 17p11.2 region, seq[GRCh37] del(17)(p11.2)(chr17:16 836 379-19 880 992). The same deletion was not found in either parent.@*CONCLUSION@#SMS is mostly diagnosed in child and adulthood, but rarely in neonates. For neonates with SMS, the neurological and behavioral abnormalities have not been shown, but pathological jaundice, CNS abnormalities and immune deficiency may be the characteristics, which require attention of neonatal physicians.


Assuntos
Adulto , Humanos , Recém-Nascido , Masculino , Deleção Cromossômica , Cromossomos Humanos Par 17 , Variações do Número de Cópias de DNA , Testes Genéticos , Deficiência Intelectual/genética , Fenótipo , Síndrome de Smith-Magenis/genética
3.
Chinese Journal of Medical Aesthetics and Cosmetology ; (6): 231-234, 2020.
Artigo em Chinês | WPRIM | ID: wpr-872141

RESUMO

Objective:To investigate the effect of pulsed dye laser combined with triamcinolone acetonide on hypertrophic scar after thyroid surgery.Methods:From August 2016 to October 2017, 76 patients (22 males and 54 females, aged between 18 and 48 years, with an average of 31 years) with hypertrophic scar after thyroid surgery in the Department of Dermatology and Cosmetology, Weihai City Hospital, Shandong Province, were divided into two groups. In the observation group, 38 patients were subjected to 595 nm pulsed dye laser combined with triamcinolone acetonide injection. In the control group, 38 patients were only locally injected with triamcinolone acetonide. Once every 4 weeks, the patients who did not recover or had a recurrence continued treatment, and the efficacy and adverse reactions were judged for 5 times in total. The patients were followed up for 1 year.Results:After treatment, 21 cases (55.26%) were cured in the observation group. 32 cases were effective, accounting for 84.21%. 4 patients in the control group were cured, accounting for 10.53%, and 16 patients were effective, accounting for 42.11%. The cure rate and effective rate in the observation group were higher than those in the control group ( χ2=5.371, 4.989, P<0.01). Conclusions:595 nm pulsed dye laser combined with local triamcinolone acetonide injection is effective in the treatment of postoperative hypertrophic scar.

4.
Journal of Clinical Pediatrics ; (12): 732-735, 2014.
Artigo em Chinês | WPRIM | ID: wpr-454092

RESUMO

Objective To explore the efficacy of duo positive airway pressure ventilation in treating preterm infant with neonatal respiratory distress syndrome (RDS). Methods 65 preterm infants admitted to the neonatal intensive care unit from December 2012 to December 2013 were randomly divided into DuoPAP group (34 cases) or NCPAP (31 cases) group. Blood gas analysis(pH value, PaO2, PaCO2 and OI) at 1h, 12h, 24h, and 72h, and incidence of apnea, pulmonary air leak, repeated application of pulmonary surfactant and non-invasive ventilation failure at 72h in the two groups were measured and compared after using intubate surfactant extubate (INSURE). Results OI after non-invasive ventilation at 1h, 12h, and 24h was signiifcantly higherin DuoPAP group than that in NCPAP group P<0.01). PaCO2 after non-invasive ventilation at 1h, 12h, 24hand 72h was signiifcantly lower in DuoPAP group than that in NCPAP group (P<0.01). PaO2 after non-invasive ventilation at 1h and 12h was higher in DuoPAP group than that in NCPAP group, and there was signiifcant difference between the two groups (P<0.01). The incidence of non-invasive ventilation failure, apnea in 72h was lower in DuoPAP group than that in NCPAP group, and there was signiifcant difference between the two groups (P<0.05). Conclusions Compared with NCPAP, DuoPAP is more feasible for improving oxygenation, decreasing the need for mechanical ventilation in 72h in preterm infants with neonatal RDS.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA